Alan Tan, MD

GU Oncology Now

<p>Alan Tan, MD, director of GU Medical Oncology and an assistant professor at RUSH Medical College, discusses the ongoing shortages of cisplatin and carboplatin supplies and how genitourinary oncology professionals and patients have been affected.<p>Cancer drug shortages have been an issue over the past decade and often occur in cycles. Cisplatin and carboplatin are widely used for the treatment of prostate cancer, and the shortages have led medical professionals to seek out alternative treatments. The shortages have been recognized as a public health emergency, and the US Food and Drug Administration is considering allowing the temporary use of drugs from outside of the United States to alleviate the ongoing issue.</p></p>


Dr. Alan Tan on Ongoing Cisplatin, Carboplatin Shortages Affecting Prostate Cancer Care

Prostate Cancer

Dr. Alan Tan discusses the ongoing cisplatin and carboplatin shortages and how they have affected prostate cancer care for both physicians and patients.

Dr. Alan Tan on Ongoing Cisplatin, Carboplatin Shortages

About Us

Contributors and Partners

Editorial Policy

Advertising

eNewsletters

Calendar

Contact Us

Contribute

MashupMD

Cancer Nursing Today

Urban Health Today

Blood Cancers Today

DocWire News

Knowledge Hubs

Conference Coverage

Roundtables

The Uromigos

Uromigos Live 2024

AUC3

Localized

mHSPC/mCSPC

CRPC

Diagnostics

Localized Renal Cell Carcinoma

Advanced Renal Cell Carcinoma

nccRCC

Renal Cell Carcinoma

Non-Muscle Invasive Urothelial Carcinoma

Muscle Invasive Urothelial Carcinoma

Advanced Urothelial Carcinoma

Upper Tract Urothelial Carcinoma

Urothelial Carcinoma

Testicular, Penile, and Rare Cancers

Video Insights

Advancements in Oncology

The Oncology Brothers

Expert Interviews

Journal

Subscribe